Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Maryland, College Park
With
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
This will be a Stage II randomized control trial to examine the efficacy of behavioral activation treatment for smoking (BATS) vs. standard smoking cessation treatment (ST). We will recruit 200 smokers with elevated depressive symptoms who will be randomized into one of two treatment groups. Treatment will be delivered in group format across both the BATS (n = 100) and ST condition (n = 100). All participants will receive 8 weeks of transdermal nicotine patch in addition to their assigned treatment group. We intend to compare the BA treatment for smoking (BATS) to a standard smoking cessation intervention (ST)on abstinence and relapse outcomes. In addition we will examine to what extent depressive symptoms and reward sensitivity prior to quit date will mediate the effects of BATS on improved smoking cessation outcomes relative to ST.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Between 18 and 65 years of age
A regular smoker for at least one year
Currently smoking an average of at least 10 cigarettes per day
Want to quit smoking
Report current elevated depressive symptoms
You may not be if
Current Axis I disorder
Psychoactive substance dependence (excluding nicotine dependence) within the past 6 months
Current use of psychotropic medication or participation in any form of psychotherapy
A history of significant medical condition (e.g., cardiovascular , neurological, gastrointestinal), pregnancy and/or breast feeding, or other systemic illness
Current use of any pharmacotherapy for smoking cessation not provided by the researchers during the quit attempt
